Loading...
Loading...
Indian Pharmaceutical Exporter Β· #14 for Fexofenadine Β· $1.7M export value Β· DGFT Verified
Zentiva Private Limited is the #14 Indian exporter of Fexofenadine with $1.7M in export value and 48 verified shipments. Zentiva Private Limited holds a 1.6% market share in Fexofenadine exports across 1 countries. The company exports 8 pharmaceutical products worth $62.4M across 4 therapeutic categories.

| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED KINGDOM | $33.8M | 794 | 37.7% |
| UNITED STATES | $17.3M | 345 | 19.2% |
| IRELAND | $11.0M | 373 | 12.2% |
| AUSTRALIA | $8.8M | 504 | 9.8% |
| BELGIUM | $5.0M | 382 | 5.6% |
| BRAZIL | $5.0M | 106 | 5.5% |
| SRI LANKA | $1.8M | 94 | 2.0% |
| NETHERLANDS | $1.3M | 45 | 1.5% |
| RUSSIA | $1.3M | 26 | 1.4% |
| CHILE | $1.1M | 36 | 1.2% |
India exports Fexofenadine to 97 countries. The top destination is UNITED KINGDOM (37.7%), followed by UNITED STATES and IRELAND.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| CHANELLE MEDICAL | IRELAND | $10.5M | 358 |
| MOVIANTO UK LTD | UNITED KINGDOM | $9.2M | 184 |
| MOVIANTO UK LIMITED | UNITED KINGDOM | $4.5M | 90 |
| ALLOGA UK LTD | UNITED KINGDOM | $4.3M | 227 |
| H.ESSERS & ZONEN INTERNATIONAL TRAN | BELGIUM | $4.2M |
India exported $81.9M worth of Fexofenadine through 4,236 shipments from 224 suppliers to 97 countries, serving 599 buyers globally. Zentiva Private Limited contributes $1.7M to this total, accounting for 1.6% of India's Fexofenadine exports.
Zentiva Private Limited's average Fexofenadine shipment value is $36.0K per consignment, based on 48 shipments totaling $1.7M.
Zentiva Private Limited ranks #14 among 224 Indian Fexofenadine exporters with a 1.6% market share. The top 3 exporters are IND SWIFT LIMITED ($14.6M), CIPLA LIMITED ($13.6M), DR.REDDY'S LABORATORIES LTD ($12.4M). Zentiva Private Limited processed 48 shipments to 1 destination countries.
What Zentiva Private Limited must comply with to export Fexofenadine to its top destination countries
Approval Process
Post-Brexit UK Marketing Authorisation via national procedure. Separate from EU approval since January 2021.
Timeline: 12β15 months
GMP & Export Requirements
UK GMP compliance; MHRA inspection of manufacturing site
Manufacturer Import Authorisation (MIA) held by UK importer; Qualified Person (QP) batch release
Note: Post-Brexit: EU GMP certificates no longer automatically valid in UK. Separate MHRA recognition required.
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Exporters ranked immediately above and below #14 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 11 | IND-SWIFT LIMITED | $2.3M | 63 | 11 | $36.8K |
| 12 | DR.REDDY'S LABORATORIES LIMITED | $1.7M | 48 | 2 | $36.3K |
| 14 | ZENTIVA PRIVATE LIMITED β | $1.7M | 48 | 1 | $36.0K |
| 15 | CADILA PHARMACEUTICALS LIMITED | $1.6M | 74 |
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 569 | 13.4% |
| JNPT/ NHAVA SHEVA SEA | 385 | 9.1% |
| SAHAR AIR CARGO ACC (INBOM4) | 362 | 8.5% |
| NHAVA SHEVA SEA (INNSA1) | 350 | 8.3% |
| HYDERABAD ICD | 229 | 5.4% |
| CHAWAPAYAL ICD | 186 | 4.4% |
| JNPT | 161 | 3.8% |
| CHAWAPAYAL ICD (INCPR6) | 142 | 3.4% |
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Zentiva Private Limited. The Israel-Iran conflict has led to increased tensions in the Red Sea, resulting in higher shipping costs and potential delays for exporters relying on these routes. Such disruptions necessitate strategic adjustments in logistics and supply chain management to maintain timely deliveries.
Conversely, the evolving trade dynamics between the U.S. and China have opened avenues for Indian pharmaceutical companies. As the U.S. seeks to diversify its supply chains, Indian exporters are well-positioned to fill the gap, provided they meet stringent regulatory standards. Additionally, the IndiaβEuropean Union Free Trade Agreement, signed in January 2026, aims to eliminate tariffs on pharmaceutical products, enhancing market access for companies like Zentiva. (en.wikipedia.org)
Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. Zentiva's manufacturing facility in Ankleshwar adheres to Good Manufacturing Practices (GMP), ensuring product quality and safety. The company's commitment to regulatory compliance is further evidenced by its strategic partnerships, such as the licensing agreement with Lupin for the biosimilar Certolizumab Pegol, which involves joint investment in development and adherence to regulatory milestones. (business-standard.com)
The European Union's Falsified Medicines Directive imposes stringent requirements on pharmaceutical imports, necessitating robust serialization and traceability measures. Zentiva's proactive approach to these regulations enhances its credibility and facilitates smoother market entry into the EU.
Zentiva Private Limited exports 8 products worth $62.4M. Beyond Fexofenadine, top products include Metformin, Clopidogrel, Paracetamol, Ramipril, Rivaroxaban. View the complete Zentiva Private Limited profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Fexofenadine β including regulatory updates, trade policy changes, and competitive landscape analysis β will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records β the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Zentiva Private Limited's Fexofenadine exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Zentiva Private Limited
Full Company Profile β
8 products Β· $62.4M total trade Β· 4 categories
| 166 |
| GRANULES CONSUMER HEALTH | UNITED STATES | $3.9M | 78 |
| GRANULES USA INC | UNITED STATES | $3.5M | 71 |
| NOUMED PHARMACEUTICALS PTY LTD | AUSTRALIA | $2.8M | 247 |
| GRANULES USA INC. | UNITED STATES | $1.8M | 36 |
| NOUMED LIFE SCINCES LIMITED | UNITED KINGDOM | $1.8M | 36 |
India's Fexofenadine is purchased by 599 buyers worldwide. The top buyer is CHANELLE MEDICAL (IRELAND), followed by MOVIANTO UK LTD and MOVIANTO UK LIMITED.
Timeline: 10β18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
| 9 |
| $21.5K |
| 10 | DR REDDY S LABORATORIES LIMITED | $1.1M | 23 | 3 | $50.0K |
Zentiva Private Limited ranks #14 among 224 Indian Fexofenadine exporters. Average shipment value of $36.0K compared to the market average of $365.5K. The closest competitors by value are IND-SWIFT LIMITED and DR.REDDY'S LABORATORIES LIMITED.
Verify manufacturer licensing and export certifications with the official agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 97+ countries, 599+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, pricing trends, and buyer contacts for Zentiva Private Limited.
Request DemoView Pricing βTrade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Fexofenadine. For current shipment-level data, contact TransData Nexus.